Polycyclo Ring System Patents (Class 568/817)
  • Patent number: 10703684
    Abstract: A bark-based composition having at least 70% by volume of bark is defibrated in order to make cultivation media having water availability that is greater than or equal to 250 mL/L.
    Type: Grant
    Filed: July 12, 2017
    Date of Patent: July 7, 2020
    Assignee: FLORENTAISE
    Inventors: Laurent Tournayre, Eric Beaudet
  • Publication number: 20150147288
    Abstract: The invention generally relates to environmental friendly pesticide compounds, formulations, methods of preparation and application and utilities thereof. More particularly, the invention relates to pesticide compounds and formulations that include terpenes or terpenoids having chemical formula of (C5H8)n, and its derivatives and analogs thereof, as active insecticidal ingredients; certain botanical essential oils as synergists, and other select ingredients as additives.
    Type: Application
    Filed: February 2, 2015
    Publication date: May 28, 2015
    Inventor: Tao Zhong
  • Publication number: 20150141633
    Abstract: The disclosure relates to a method for enhancing the biosynthesis and/or secretion of sapogenins in the culture medium of plant and microbial cell cultures. Further, the disclosure also relates to the identification of novel genes involved in the biosynthesis of sapogenin intermediates, as well as to novel sapogenin compounds.
    Type: Application
    Filed: May 13, 2013
    Publication date: May 21, 2015
    Inventors: Alain Goossens, Tessa Moses, Jacob Pollier, Lorena Almagro Romero
  • Patent number: 9029414
    Abstract: The present invention provides therapeutically active compounds and compositions as receptor antagonists and methods of use thereof. In one aspect, the compounds are useful in modulating pain, inflammation and acute phase reactions by inhibiting the PGE2 receptors including PGE2 EP1, EP2 and EP4 receptors.
    Type: Grant
    Filed: September 19, 2009
    Date of Patent: May 12, 2015
    Assignee: Biotechnology Research Corporation
    Inventors: Nancy Yuk-Yu Ip, Fanny Chui-Fun Ip, Yueqing Hu
  • Patent number: 9024043
    Abstract: This invention discloses diterpenes class of novel compounds of general formula I from a novel source. More particularly the invention relates to extracts/fractions containing pimarane diterpenes from Anisochillus (Lamiaceae), useful for prevention, treatment, inhibition or controlling growth and proliferation of mycobacterial activity in mammals. The invention further relates to extracts, fractions standardized to diterpenes class of novel compounds useful for the treatment of cancers.
    Type: Grant
    Filed: August 6, 2012
    Date of Patent: May 5, 2015
    Assignee: Council of Scientific & Industrial Research
    Inventors: Swati Pramod Joshi, Roshan Rajan Kulkarni
  • Publication number: 20150105460
    Abstract: Provided in the present invention are various labdane diterpenoid compounds and derivatives thereof for use in preparation of a pharmaceutical composition for preventing or treating neurodegenerative diseases. Also provided in the present invention is a semen biotae extract comprising one or more labdane diterpenoid compounds and derivatives thereof for use in preparation of a pharmaceutical composition for preventing or treating neurodegenerative diseases.
    Type: Application
    Filed: June 4, 2012
    Publication date: April 16, 2015
    Inventors: Weiwei Su, Yonggang Wang, Fengyin Liang, Ning Wang, Zhong Pei, Haibin Liu
  • Patent number: 8987526
    Abstract: Provided are a novel fullerene derivative which can adsorb quickly and efficiently an allergen which may cause a pollen allergy without releasing the allergen again, does not contain a metal or the like which may cause a harmful effect to a human body, and is easily applicable, impregnable, or chemically bondable onto surface of various materials: and a process for producing the same. The fullerene derivative is characterized in that a halogen group and many hydroxyl groups are bonded directly to a fullerene nucleus. In the case that the halogen group is chlorine, the fullerene derivative can be synthesized by a partial hydroxylation of a chlorinated fullerene or a partial chlorination of a hydroxylated fullerene.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: March 24, 2015
    Assignees: Osaka University, Totai Co., Ltd.
    Inventors: Ken Kokubo, Takeshi Noguchi
  • Publication number: 20150011802
    Abstract: Provided are a novel fullerene derivative which can adsorb quickly and efficiently an allergen which may cause a pollen allergy without releasing the allergen again, does not contain a metal or the like which may cause a harmful effect to a human body, and is easily applicable, impregnable, or chemically bondable onto surface of various materials: and a process for producing the same. The fullerene derivative is characterized in that a halogen group and many hydroxyl groups are bonded directly to a fullerene nucleus. In the case that the halogen group is chlorine, the fullerene derivative can be synthesized by a partial hydroxylation of a chlorinated fullerene or a partial chlorination of a hydroxylated fullerene.
    Type: Application
    Filed: September 24, 2014
    Publication date: January 8, 2015
    Applicants: Osaka University, Totai Co., Ltd.
    Inventors: Ken KOKUBO, Takeshi Noguchi
  • Patent number: 8927594
    Abstract: The invention relates to compounds from the soft coral and the generation thereof. The invention also relates to the uses of the compounds from the soft coral in inhibiting inducible nitric oxide synthase and/or cyclooxygenase-2 and in treating the diseases associated with inducible nitric oxide synthase and/or cyclooxygenase-2.
    Type: Grant
    Filed: March 15, 2011
    Date of Patent: January 6, 2015
    Assignees: National Sun Yat-Sen University, National Museum of Marine Biology & Aquarium
    Inventors: Jyh-Horng Sheu, Wei-Hsien Wang, Zhi-Hong Wen, Bo-Wei Chen, Ping-Jyun Sung
  • Publication number: 20140350100
    Abstract: The present disclosure provides novel glucagon-like peptide-1 (GLP-1) receptor modulators such as compounds of Formula (I) or (II), and pharmaceutically acceptable salts thereof. The present disclosure also provides pharmaceutical compositions, kits, and uses that involve the GLP-1 receptor modulators for regulating blood glucose levels and/or treating diabetes via, e.g., modulating the endogenous signaling pathways mediated by the GLP-1 receptor.
    Type: Application
    Filed: May 27, 2014
    Publication date: November 27, 2014
    Applicants: Academia Sinica
    Inventors: Klim King, Rong-Jie Chein
  • Publication number: 20140275323
    Abstract: Oligomer-grafted nanofiller compositions and composites including oligomer-grafted nanofillers are disclosed. An oligomer-grafted nanofiller composition for disposition in a polymer matrix, the polymeric matrix comprising polymers derived from a plurality of polymerizable units, can include a nanoparticle, one or more coupling groups bonded to the nanoparticle; and one or more oligomers bonded to the one or more coupling groups. In an embodiment the oligomer is derived from two or more polymerizable units, at least one polymerizable unit being at least substantially similar to at least one of the polymerizable units of the polymer matrix. In another embodiment the oligomer comprises two or more polymerizable units and improves dispersion, interfacial strength, or both dispersion and interfacial strength between the nanoparticle and the polymer matrix. Composites and methods are also disclosed.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: Francis R. Thibodeau, Yuqiang Qian, Andreas Stein, Christopher W. Macosko
  • Publication number: 20140212750
    Abstract: Disclosed is an anode active material for lithium secondary batteries that includes natural graphite particles consisting of spherical particles of agglomerated graphite sheets, outer surfaces of which are not coated with a carbon-based material, wherein the surfaces of the particles have a degree of amorphization of at least 0.3 within a range within which an R value [R=I1350/I1580] (I1350 is the intensity of Raman around 1350 cm?1 and I1580 is the intensity of Raman around 1580 cm?1) of a Raman spectrum is in the range of 0.30 to 1.0.
    Type: Application
    Filed: March 31, 2014
    Publication date: July 31, 2014
    Applicant: LG CHEM, LTD.
    Inventors: Byoung Hoon Ahn, Chang-Wan Koo, Joon Sung Bae, Jae Bin Chung
  • Patent number: 8784520
    Abstract: Methods of treating a plurality of particles involve functionalizing a plurality of microscale diamond particles by covalently bonding one or more molecular groups selected from OH functional groups, —COOH functional groups, —R—COOH functional groups, wherein R includes alkyls, -Ph-COOH functional groups, wherein Ph includes phenolics, polymers, oligomers, monomers, glycols, sugars, ionic functional groups, metallic functional groups, and organo-metallic functional groups to outer surfaces of at least some particles of the plurality of microscale diamond particles. A stability of the functionalized plurality of microscale diamond particles in dispersion is increased as compared to a plurality of microscale diamond particles that has not been functionalized.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: July 22, 2014
    Assignee: Baker Hughes Incorporated
    Inventors: Soma Chakraborty, Gaurav Agrawal
  • Patent number: 8771629
    Abstract: Included are a nano-carbon material production unit for producing a nano-carbon material using a fluidized catalyst formed by granulating a carrier supporting an active component, an acid treatment unit for dissolving and separating a catalyst by an acid solution by feeding a catalyst-containing nano-carbon material into the acid solution, and a pH adjustment unit, which is an anti-agglomeration treatment unit, provided on a downstream side of the acid treatment unit, for performing an anti-agglomeration treatment to prevent agglomeration among nano-carbons due to repulsion caused by dissociation among oxygen-containing functional groups added to the nano-carbon material.
    Type: Grant
    Filed: May 28, 2009
    Date of Patent: July 8, 2014
    Assignee: Mitsubishi Heavy Industries, Ltd.
    Inventors: Kiyoshi Tatsuhara, Tomoaki Sugiyama, Atsushi Tanaka, Toshihiko Setoguchi
  • Publication number: 20140171662
    Abstract: This invention discloses diterpenes class of novel compounds of general formula I from a novel source. More particularly the invention relates to extracts/fractions containing pimarane diterpenes from Anisochillus (Lamiaceae), useful for prevention, treatment, inhibition or controlling growth and proliferation of mycobacterial activity in mammals. The invention further relates to extracts, fractions standardized to diterpenes class of novel compounds useful for the treatment of cancers.
    Type: Application
    Filed: August 6, 2012
    Publication date: June 19, 2014
    Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Swati Pramod Joshi, Roshan Rajan Kulkarni
  • Publication number: 20140056995
    Abstract: Novel Uses of small molecules, particularly, triterpenoids and ingol diterpenes isolated from Euphorbia neriifolia, are disclosed herein. The triterpenoids are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating cancer; whereas the ingol diterpenes are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating thrombocytopenia.
    Type: Application
    Filed: August 27, 2012
    Publication date: February 27, 2014
    Applicant: Mackay Memorial Hospital
    Inventors: YU-JEN CHEN, Lie-Chwn Lin, Ching-Pin Lin
  • Patent number: 8617608
    Abstract: The present disclosure generally relates to nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: May 28, 2013
    Date of Patent: December 31, 2013
    Assignee: BIND Therapeutics, Inc.
    Inventors: Stephen E. Zale, Greg Troiano, Mir Mukkaram Ali, Jeff Hrkach, James Wright
  • Patent number: 8613954
    Abstract: The present disclosure generally relates to nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: April 12, 2013
    Date of Patent: December 24, 2013
    Assignee: BIND Therapeutics, Inc.
    Inventors: Stephen E. Zale, Greg Troiano, Mir Mukkaram Ali, Jeff Hrkach, James Wright
  • Publication number: 20130287707
    Abstract: As a novel compound which is excellent in odor quality and has an odor of a very clear and strong woody note, the invention provides a compound represented by the following formula (1):
    Type: Application
    Filed: April 19, 2013
    Publication date: October 31, 2013
    Applicant: Takasago International Corporation
    Inventors: Kyoko ZAIZEN, Tsuyoshi Kobayashi, Junko Nagano, Yoshihiro Yaguchi
  • Patent number: 8563041
    Abstract: Disclosed herein are therapeutic compositions for treating and preventing diseases such as neointimal hyperplasia (NIH), where the compositions comprise a therapeutic particle that has a localized association with a blood vessel and a therapeutic agent, such as an anti-NIH agent. Methods of use of the therapeutic compositions are also disclosed.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: October 22, 2013
    Assignee: BIND Therapeutics, Inc.
    Inventors: Amy Grayson, Stephen E. Zale, David Dewitt
  • Publication number: 20130274256
    Abstract: Certain multi-cyclic compounds and compositions thereof are useful for reducing or inhibiting the growth of bacterial biofilms and for controlling bacterial biofilm infections. Such compounds and compositions are also useful in methods for reducing or inhibiting the growth of biofilms and for controlling bacterial biofilm infections involving biofilms.
    Type: Application
    Filed: October 11, 2012
    Publication date: October 17, 2013
    Applicant: SEQUOIA SCIENCES, INC.
    Inventor: Sequoia Sciences, Inc.
  • Publication number: 20130203718
    Abstract: The present invention relates to a compound of formula (I): for its use as progesterone receptor antagonist, in particular for its use for the prevention and/or the treatment of cancer or uterine pathologies.
    Type: Application
    Filed: May 9, 2011
    Publication date: August 8, 2013
    Inventors: Marie-Edith Rafestin-Oblin, Mouad Alami, Hugues Loosfelt, Abdallah Hamze, Ali Junaid Khan, Abdellatif Tikad, Marc Lombes, Jean-Daniel Brion
  • Publication number: 20130190538
    Abstract: A process for the preparation of protoescigenin by hydrolysis of escin isolated from Aesculus hippocastanum. The process includes the following steps: a two-step hydrolysis first under acidic and then basic conditions, enrichment of the crude mixture of sapogenins with protoescigenin, an isolation of the mixture of sapogenins in a solid form, and a purification of the obtained solid and isolation of high purity protoescigenin. The invention also relates to protoescigenin monohydrate in a crystalline form and the preparation thereof. Protoescigenin is a polyhydroxy aglycone, which can be used as a synthon in the chemical modifications of naturally occurring saponins.
    Type: Application
    Filed: January 3, 2013
    Publication date: July 25, 2013
    Applicants: WARSZAWSKI UNIWERSYTET MEDYCZNY, INSTYTUT FARMACEUTYCZNY
    Inventors: INSTYTUT FARMACEUTYCZNY, WARSZAWSKI UNIWERSYTET MEDYCZNY
  • Publication number: 20130144072
    Abstract: Compounds are attached to carbon nanotubes (CNT) by a process which comprises: subjecting surface treated CNTs which have been treated to induce negatively charged surface groups thereon, to nucleophilic substitution reaction with a compound carrying a functional group capable of reacting with the negatively charged groups on the CNT surface, whereby the compound chemically bonds to the CNT. The surface CNT treatment may be reduction. The compounds which are bonded to the CNT may be epoxy resins, bonded directly or through a spacer group. Bi-functional CNTs, grafted to both epoxy resins and other polymers such as polystyrene, are also made by this process.
    Type: Application
    Filed: January 29, 2013
    Publication date: June 6, 2013
    Applicant: NATIONAL RESEARCH COUNCIL OF CANADA
    Inventor: NATIONAL RESEARCH COUNCIL OF CANADA
  • Patent number: 8450533
    Abstract: A method for the preparation of cyclopropyl carbinols by cyclopropanation of unsaturated alcoholates, utilizing a reagent system selected from (A) magnesium metal and dibromomethane, and (B) dibromomethane and a tertiary Grignard reagent, the reaction being carried out in the presence of an ether solvent. The process is useful, for example, for the preparation of ingredients for the flavor and fragrance industry.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: May 28, 2013
    Assignee: Givaudan SA
    Inventor: Fridtjof Schroder
  • Publication number: 20130000209
    Abstract: Methods of treating a plurality of particles comprise functionalizing a plurality of microscale diamond particles by covalently bonding one or more molecular groups selected from the group consisting of —OH functional groups, —COOH functional groups, —R—COOH functional groups, wherein R comprises alkyls, —Ph—COOH functional groups, wherein Ph comprises phenolics, polymers, oligomers, monomers, glycols, sugars, ionic functional groups, metallic functional groups, and organo-metallic functional groups to outer surfaces of at least some particles of the plurality of microscale diamond particles. A stability of the functionalized plurality of microscale diamond particles in dispersion is increased as compared to a plurality of microscale diamond particles that has not been functionalized.
    Type: Application
    Filed: June 30, 2011
    Publication date: January 3, 2013
    Applicant: BAKER HUGHES INCORPORATED
    Inventors: Soma Chakraborty, Gaurav Agrawal
  • Patent number: 8318208
    Abstract: The present disclosure generally relates to nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: November 27, 2012
    Assignee: Bind Biosciences, Inc.
    Inventors: Stephen E. Zale, Greg Troiano, Mir Mukkaram Ali, Jeff Hrkach, James Wright
  • Patent number: 8273906
    Abstract: It is intended to provide a method for producing aglycone from a glycoside efficiently at low cost without using an acid catalyst or an organic solvent. The method for producing aglycone, characterized by bringing a glycoside into contact with high temperature high pressure water. The temperature of the high temperature high pressure water is generally from 100 to 374° C., preferably from 140 to 320° C., more preferably from 200 to 300° C. The pressure of the high temperature high pressure water may be not lower than the saturated water vapor pressure at the temperature, i.e., a pressure at which the liquid state is maintained.
    Type: Grant
    Filed: June 13, 2008
    Date of Patent: September 25, 2012
    Assignee: J-Oil Mills, Inc.
    Inventors: Yosuke Isobe, Shuichi Kamo, Toshiro Sato, Hiroyuki Yoshida
  • Patent number: 8206747
    Abstract: The present disclosure generally relates to nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. Other aspects of the invention include methods of making such nanoparticles.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: June 26, 2012
    Assignee: BIND Biosciences, Inc.
    Inventors: Stephen E. Zale, Greg Troiano, Mir Mukkaram Ali, Jeff Hrkach, James Wright
  • Publication number: 20120156611
    Abstract: Phenolic molecular glasses such as calixarenes include at least one fluoroalcohol containing unit. The fluoroalcohol containing molecular glasses can be used in photoresist compositions. Also disclosed are processes for generating a resist image on a substrate using the photoresist composition.
    Type: Application
    Filed: December 17, 2010
    Publication date: June 21, 2012
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Luisa D. Bozano, Gregory Breyta, Ekmini A. DeSilva, William D. Hinsberg, Ratnam Sooriyakumaran, Linda K. Sundberg
  • Publication number: 20120129924
    Abstract: The present invention relates to a pharmaceutical composition for preventing or treating hyperlipidemia, fatty liver, diabetes and obesity comprising a sesquiterpene derivative as an active ingredient. The sesquiterpene derivatives of the present invention leads to decrease in body fat weight, visceral fat weight and total cholesterol levels, triglyceride of plasma and liver tissue, blood glucose and blood insulin levels in a fast state, finally exhibiting efficacies on prevention or treatment of hyperlipidemia, fatty liver, diabetes and obesity.
    Type: Application
    Filed: October 20, 2008
    Publication date: May 24, 2012
    Applicant: KWANG DONG PHARM. CO., LTD.
    Inventors: Tae-Sun Park, Ha-Won Kim
  • Publication number: 20120088939
    Abstract: Provided is a hyaluronic acid production promoter and a melanin synthesis inhibitor. The hyaluronic acid production promoter and the melanin synthesis inhibitor of the present invention each contain soybean saponin as an active ingredient. The soybean saponin is preferably soybean saponin aglycone. The soybean saponin aglycone preferably includes soyasapogenol A and/or soyasapogenol B. The hyaluronic acid production promoter and the melanin synthesis inhibitor of the present invention are each administered transdermally or orally.
    Type: Application
    Filed: May 25, 2010
    Publication date: April 12, 2012
    Applicant: J-Oil Mills, Inc.
    Inventors: Shuichi Kamo, Shunsuke Suzuki, Toshiro Sato
  • Patent number: 8134033
    Abstract: To provide a novel polymerizable fluorocompound having a highly fluorinated norbornane structure, and a polymer obtained from the compound. Further, their production processes and a novel intermediate useful for the processes. A novel compound (1) such as a compound (11) or a compound (12), and its polymer. A compound (2) such as a compound (21) or (22), and a compound (3) such as a compound (31) or (32M), which are useful as an intermediate for the production of the compound (1), and its production process. However, each of ZA to ZE represents such as —CH(—OC(O)C(CH3)?CH2)— or —CF2, Each of WA and WB represents such as F, each of YA to YE represents such as —CH(—OH)— or —CF(CH2OH), and each of XA to XE represents such as —C(O)— or —CF2—.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: March 13, 2012
    Assignee: Asahi Glass Company, Limited
    Inventors: Yasuhisa Matsukawa, Daisuke Shirakawa, Eisuke Murotani, Naoko Shirota, Yoko Takebe
  • Publication number: 20110293757
    Abstract: Compositions for the treatment and/or prevention of cancer are described. Preferably the composition comprises a therapeutically effective amount of tea tree oil from Melaleuca alternifolia, together with a pharmaceutically or therapeutically acceptable carrier and/or diluent. Methods for the treatment and/or prevention of cancer are also described. Preferably the method is used for the treatment and prevention of skin cancer. More preferably, the method is used for the treatment and prevention of basal cell carcinoma, squamous cell carcinoma and/or melanoma.
    Type: Application
    Filed: July 17, 2009
    Publication date: December 1, 2011
    Applicant: Novasel Australia Pty. Ltd.
    Inventors: Thomas V. Riley, Sara J. Greay, Christine F. Carson, Manfred W. Beilharz, Demelza J. Ireland, Haydn T. Kissick
  • Publication number: 20110288169
    Abstract: The present invention provides therapeutically active compounds and compositions as receptor antagonists and methods of use thereof. In one aspect, the compounds are useful in modulating pain, inflammation and acute phase reactions by inhibiting the PGE2 receptors including PGE2 EP1, EP2 and EP4 receptors.
    Type: Application
    Filed: September 19, 2009
    Publication date: November 24, 2011
    Inventors: Nancy Yuk-Yu Ip, Fanny Chui-Fun Ip, Yueqing Hu
  • Patent number: 8049042
    Abstract: To provide a resist polymer comprising, as a structural unit, an acid-decomposable unit having a structure represented by formula (1) or (2) which exhibits a small line edge roughness and produces little defects in DUV excimer laser lithography or the like.
    Type: Grant
    Filed: March 26, 2009
    Date of Patent: November 1, 2011
    Assignee: Mitsubishi Rayon Co., Ltd.
    Inventors: Hikaru Momose, Atsushi Ootake, Tadashi Nakamura, Akifumi Ueda
  • Publication number: 20110124924
    Abstract: A method for the preparation of cyclopropyl carbinols by cyclopropanation of unsaturated alcoholates, utilising a reagent system selected from (A) magnesium metal and dibromomethane, and (B) dibromomethane and a tertiary Grignard reagent, the reaction being carried out in the presence of an ether solvent. The process is useful, for example, for the preparation of ingredients for the flavour and fragrance industry.
    Type: Application
    Filed: August 19, 2008
    Publication date: May 26, 2011
    Applicant: GIVAUDAN SA
    Inventor: Fridtjof Schroder
  • Publication number: 20110082053
    Abstract: Provided is a molecular rectifier comprised of a diamondoid molecule and an electron acceptor attached to the diamondoid molecule. The electron acceptor is generally an electron accepting aromatic species which is covalently attached to the diamondoid.
    Type: Application
    Filed: January 30, 2009
    Publication date: April 7, 2011
    Inventors: Wanli Yang, Zhi-Xun Shen, Harindran C. Manoharan, Nicholas A. Melosh, Michael A. Kelly, Andrey A. Fokin, Peter R. Schreiner, Jason C. Randel
  • Publication number: 20110060162
    Abstract: Included are a nano-carbon material production unit for producing a nano-carbon material using a fluidized catalyst formed by granulating a carrier supporting an active component, an acid treatment unit for dissolving and separating a catalyst by an acid solution by feeding a catalyst-containing nano-carbon material into the acid solution, and a pH adjustment unit, which is an anti-agglomeration treatment unit, provided on a downstream side of the acid treatment unit, for performing an anti-agglomeration treatment to prevent agglomeration among nano-carbons due to repulsion caused by dissociation among oxygen-containing functional groups added to the nano-carbon material.
    Type: Application
    Filed: May 28, 2009
    Publication date: March 10, 2011
    Applicant: MITSUBISHI HEAVY INDUSTRIES, LTD.
    Inventors: Kiyoshi Tatsuhara, Tomoaki Sugiyama, Atsushi Tanaka, Toshihiko Setoguchi
  • Publication number: 20110053050
    Abstract: The present invention relates to a method of functionalizing a carbon material. A carbon material is contacted with a carboxylic acid, whereby a mixture is formed. The mixture is heated for a suitable period of time at a temperature below the thermal decomposition temperature of the carbon material.
    Type: Application
    Filed: October 18, 2007
    Publication date: March 3, 2011
    Applicant: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: San Hua Lim, Chee Kok Poh, Jianyi Lin
  • Publication number: 20110052915
    Abstract: [Task to be Solved] One of the principal objects of the invention is to collect minute diamond particles of D50 of 20 nm and smaller, by MICROTRAC UPA 150, in high precision and high definition. [Means for Solving the Task] The minute diamond particles of the invention are recovered by a method comprising: (1) joining or combining a hydrophilic functional group with a surface of diamond powder that comprises particles of a primary particle size of 50 nm or less, so as to impart hydrophilic nature on the surface, (2) placing the hydrophilic diamond particles to hold in suspension in water to form a slurry, (3) subjecting said slurry to a hyper-centrifugal process at a centrifugal force of 4×103 G and at the same time a centrifugal load product of 200×103 G·min.
    Type: Application
    Filed: February 8, 2008
    Publication date: March 3, 2011
    Inventors: Youichi Morita, Tatsuya Takimoto, Naoki Komatsu, Hiroshi Yamanaka, Hisao Shirasawa, Hiroshi Ishizuka
  • Publication number: 20110021848
    Abstract: The present invention includes wickerol and a method for producing the wickerol. In the method for producing the wickerol, Trichoderma atroviride strain FKI-3737 (FERM ABP-11099 corresponding to FERM BP-11099) belonging to filamentous fungi is cultured in a medium, and the wickerol is accumulated in a culture, and then the produced wickerol is isolated and purified from the culture. A substance having inhibitory activity against influenza virus replication and containing the wickerol as an active ingredient, and an anti-influenza drug containing the wickerol as an active ingredient are obtained.
    Type: Application
    Filed: March 12, 2009
    Publication date: January 27, 2011
    Applicant: THE KITASATO INSTITUTE
    Inventors: Satoshi Omura, Kazuro Shiomi, Rokuro Masuma, Hideaki Ui, Takayuki Nagai, Haruki Yamada
  • Publication number: 20100273801
    Abstract: The invention relates to compouns derived from betulin, and to the use thereof as antibacterial agents in pharmaceutical and cosmetic applications.
    Type: Application
    Filed: June 6, 2007
    Publication date: October 28, 2010
    Applicant: Valition teknillinen tutikimuskeskus
    Inventors: Jari Yli-Kauhaluoma, Salme Koskimies, Sami Alakurtti, Taru Mäkelä, Päivi Tammela
  • Publication number: 20090253943
    Abstract: The present invention provides birch bark pellets that include outer birch bark. The present invention also provides methods of manufacturing birch bark pellets from outer birch bark. The present invention also provides methods for obtaining a natural product from birch bark pellets. The birch bark pellets are manufactured from outer birch bark that includes relatively low amounts of inner birch bark and wood. The birch bark pellets meet the requirement for extraction, to obtain e.g., betulin and/or lupeol from the pellets.
    Type: Application
    Filed: February 27, 2009
    Publication date: October 8, 2009
    Applicant: Myriad Genetics, Incorporated
    Inventors: Christian Edwardson, Christopher Shallice
  • Publication number: 20090156856
    Abstract: The present invention provides a lubricating oil comprising an alicyclic compound represented by a general formula (I): wherein n is an integer of 0 or 1; one of R1 and R2 represents —CH2OR4 (wherein R4 represents a carboxylic acid residue) while the other one represents alkyl, lower alkyl-substituted or unsubstituted cycloalkyl, aryl, or aralkyl; and R3 represents —CH2OR5 (wherein R5 represents a carboxylic residue) and the like. The lubricating oil of the present invention has an excellent traction coefficient, excellent heat resistance, or the like. For the lubricating oil of the present invention, the alicyclic compound represented by the general formula (I) can be directly used as it is, and other base oils such as ester oil, poly-?-olefin, mineral oil, or silicone oil may be included therein, if necessary.
    Type: Application
    Filed: September 13, 2006
    Publication date: June 18, 2009
    Applicant: KYOWA HAKKO CHEMICAL CO., LTD.
    Inventors: Suguru Ohara, Satoshi Hiyoshi, Yukihiro Isogai, Makoto Goto
  • Patent number: 7507865
    Abstract: Procedure to obtain the hydrate of calcipotriol. A procedure is described, used to obtain the hydrate of calcipotriol, which consists of the reaction of anhydrous calcipotriol in water, in the absence of organic solvents.
    Type: Grant
    Filed: December 28, 2007
    Date of Patent: March 24, 2009
    Assignee: Laboratorios Vinas, S.A.
    Inventors: Antonio Buxadé Viñas, Antonio Conchillo Teruel, Carlos Mola Soler
  • Patent number: 7495135
    Abstract: The invention provides alkene fluoroalkanol and fluorinated polyol precursors to fluoroalkanol-substituted ?,?-unsaturated esters. The fluoroalkanol-substituted ?,?-unsaturated esters are olefins that can be readily polymerized to provide fluoroalkanol-substituted polymers useful in lithographic photoresist compositions. Also provided are methods for synthesizing the alkene fluoroalkanol and fluorinated polyol precursors.
    Type: Grant
    Filed: December 4, 2003
    Date of Patent: February 24, 2009
    Assignee: International Business Machines Corporation
    Inventors: Gregory Breyta, Richard Anthony DiPietro, Daniel Joseph Dawson
  • Publication number: 20090030242
    Abstract: The invention relates to a polycarbonate diol, comprising an organic residue derived from a diol component represented by formula (1), wherein n is 0 or an integer of 1 to 4, and the norbornane structure or the cyclopentane structure may be substituted with a halogen group or a hydrocarbon group. The polycarbonate diol according to the present invention can give a polyurethane resin having excellent heat resistance and flexibility in a well-balanced manner and reliability in long-term insulating properties under high temperature/high humidity conditions.
    Type: Application
    Filed: April 5, 2006
    Publication date: January 29, 2009
    Applicant: SHOWA DENKO KK
    Inventors: Hiroshi Uchida, Ritsuko Hirakawa
  • Patent number: 7470499
    Abstract: A noble alicyclic unsaturated compound represented by the general formula (1): wherein at least one of R1 and R2 is a fluorine atom or a fluorinated alkyl group; a polymer formed by the polymerization of a polymer precursor comprising the alicyclic compound. The polymer is useful, in the lithography using a light having a wavelength of 190 nm or less, as a chemically amplified resist which exhibits excellent transparency with respect to the light for use in exposure and also is excellent in the adhesion to a substrate and the resistance to dry etching.
    Type: Grant
    Filed: March 4, 2004
    Date of Patent: December 30, 2008
    Assignee: NEC Corporation
    Inventors: Katsumi Maeda, Kaichiro Nakano
  • Publication number: 20080248990
    Abstract: The use as fragrance ingredient of a compound of formula (I) wherein R1 and Y have the same meaning as given in the description, and fragrance applications comprising them.
    Type: Application
    Filed: September 8, 2006
    Publication date: October 9, 2008
    Applicant: GIVAUDAN SA
    Inventors: Jerzy A. Bajgrowicz, Iris Frank